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Abstract
Background: Tuberculosis (TB) co-infection with HIV is becoming a global emergency especially in the sub-Saharan 
Africa. Its diagnosis is notoriously challenging in countries with poor resource settings with limited diagnostic facilities.
Objective: To determine the prevalence, pattern, outcome, and clinical risk factors of TB in HIV co-infected children in 
Abuja, Nigeria.
Materials and Methods: An 18 months retrospective review of HIV-infected children diagnosed as having co-infection 
with TB was carried out at the special treatment clinic of the University of Abuja Teaching Hospital (UATH), Gwagwalada, 
from February 2007 to August 2008 for the above objectives.
Results: Of a total 210 HIV-infected children observed during the review period, 41 (19.5%) were diagnosed as 
having co-existing TB. Their mean age, weight, CD4 cell count and its percentage were 6.3 ± 2.4 years, 14.3 ± 3.4 kg, 
262 ± 28.0 cells/ml, and 9.9%, respectively. Pulmonary TB accounted for 59% of all TB cases seen, while disseminated 
form was seen in 26.8%. Bone involvement was the least common form seen in only (2.4%) of cases. Confirmation of 
TB was only possible by positive smear and histology in 22.0% of cases, while 78.0% of cases remained unconfirmed. 
Co-infection was significantly higher in older children (>5 years) than in younger children <5 years (32 vs 9, P < 0.05). 
Severe weight loss was the only clinical feature found to have a fairly good sensitivity (88.9%) and specificity (88.6%) 
for TB in co-infected children, with a positive predictive value of 23.0%. While immune reconstitution syndrome (IRS) 
occurred in 2 (4.9%) of the patients, only one death (2.4%) was recorded among the co-infected children.
Conclusions: TB co-infection with HIV in children is common in this environment. Severe weight loss can be used 
as a clinical guide to identify HIV-infected children at risk of co-infection with TB who will require further evaluation.
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Introduction
At present, worldwide over one million children are infected 
with tuberculosis (TB) and 630,000 by HIV annually.[1,2] 
While TB alone is responsible for over 250,000 deaths 
every year, HIV is projected to cause more than 56,000 
deaths worldwide annually[3,4] Co-infection with both 
organisms, also described as “cursed duet” or “deadly duo”, 
is becoming an increasing global emergency especially in the 
sub-Saharan Africa [SSA], where between 10% and 60% of 
the children are co-infected.[5] While the highest cases of 
co-infection occurred in South Africa, the least ones were 
recorded in West Africa,[5,6] and people living with HIV/
AIDS have six times greater risk of dying from active TB.[7]
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HIV infection has been known to weaken the immune 
system by depleting the CD4 cell counts and in turn 
giving room for opportunistic infections. TB itself can also 
lower the CD4 cell count in children and exacerbate the 
immunodeficiency caused by HIV infection.[7,8] Children 
infected with HIV have 50 times greater risk of developing 
primary progressive TB in a given year from severe immune 
suppression of young age and HIV infection,[5] Those with 
co-infection also have a higher case fatality rate.[9,10]
Diagnosis of TB in children has been notoriously challenging 
even before the HIV/AIDS pandemic; especially in 
resource-limited settings where culture proven facilities, 
polymerase chain reaction (PCR) test, and other newer 
diagnostic methods might not be feasible because of cost. 
Diagnosis is even more difficult with HIV pandemic 
because the affected children may have many other acute/
chronic lung disease conditions that could mimic signs and 
symptoms of TB.[5] Most TB diagnostic criteria [chronic 
cough, hemoptysis, weight loss, night sweats, history of 
contact, positive Mantoux of >5 mm diameter, chest 
radiograph, high electrolyte sedimentation rate (ESR), and 
response to treatment] have low sensitivity and specificity in 
co-infected children due to overlap with common childhood 
diseases.[5,9] Studies of TB co-infection with HIV in children 
have been reported in both industrialized[10-12] and non-
industrialized countries,[3,9,13] with proportions ranging 
from 5.5% in United Kingdom, to 17% in Peru. The true 
prevalence and magnitude of TB co-infection with HIV in 
children in Nigeria has remained under-reported. The aim 
of the present study is to determine the prevalence, pattern, 
outcome, and clinical risk factors of TB in HIV co-infected 
children. It is believed that such outcome will assist pediatric 
healthcare providers in identifying the risk of co-infected 
children, and possible referral for further evaluations.
Materials and Methods
The case records of HIV-positive children seen in pediatric 
outpatient special treatment clinic (POSTC) of UATH 
from February 2007 to August 2008 were retrieved from the 
medical records department of the hospital, and information 
collected were analyzed. Data extracted from the records 
included: HIV status of the child, diagnosis of TB in the 
patient, modalities used for the diagnosis, history of presenting 
complaint, clinical findings, sex, age, weight, whether 
admitted or not, outcome of the admission, CD4 cell count 
and its percentage, whether started on anti-TB drugs, and 
whether on highly active anti-retroviral therapy (HAART). 
The outcome of admission was classified as discharge with or 
without development of immune reconstitution syndrome 
(IRS), died, or absconded. Diagnosis of HIV infection in 
children less than 18 months was confirmed using DNA-
PCR test after 6 weeks of age. For those aged greater than 
18 months, the diagnosis was by double rapid antibody test 
[STAT PAK by chembio diagnostic system INC New York, 
and DETERMINE by Abbot Laboratory Japan]. POSTC is a 
specialized clinic for HIV/AIDS children, and an arm of the 
pediatric outpatient clinic of the department.
University of Abuja Teaching Hospital is a tertiary health 
institution located in Gwagwalada, one of the area councils 
in the Federal Capital Territory (FCT), Abuja in the North 
Central Zone of the country. The institution is sub-serving 
many states including Nassarawa, Kogi, Niger, Benue, 
parts of Kaduna and FCT, Abuja. It is also one of the first 
six centers in the country to provide free medical services 
to HIV/AIDS victims from 2005 till date, courtesy of the 
government of the United States through the President’s 
Emergency Plan for AIDS Relief (PEPFAR).
Diagnosis of TB was made using combination of the 
following: History of chronic cough >1 month, history of 
contact with adult with chronic cough, positive mantoux 
test of >5 mm in diameter, chest radiograph, identification 
of acid fast bacilli (AFB) in sputum/gastric/body fluid, 
lymph node histology, history of ingestion of unpasteurized 
cow milk, history of night sweats, and non response to 
conventional antibiotics. No culture was carried out. 
A combination of more than two of the above findings was 
used for diagnosis of TB in our center.
Pulmonary TB was confirmed when the child has specific 
clinical and radiological criteria (fever, cough of >1 month 
duration, weight loss, history of contact with adult with 
chronic cough, night sweats, and at least one positive 
smear test of sputum or gastric aspirate). Confirmed extra 
pulmonary TB was diagnosed when the child had specific 
clinical criteria (lymph node enlargement, ascites, and 
history of ingestion of unpasturized milk, bone involvement, 
radiological features, meningitic signs, and lymph node 
histology confirming TB, or positive smear from other body 
fluid other than sputum). Non confirmed TB was considered 
when the child had specific clinical and radiological 
criteria mentioned above, and had no histological features 
suggestive of TB in the lymph node biopsy, or when AFB 
was not isolated in sputum or any other body fluid.
Sputum for AFB was obtained by expectoration (×3) for 
older children, and early morning gastric lavage (×3) for 
those less than 3 years who cannot expectorate. Sputum, 
gastric aspirate, and other body fluid aspirates were stained 
for acid-fast bacilli using Ziel-Nelson method. Tuberculin 
skin tests were performed by intradermal injection of 5 
tuberculin units of purified protein derivatives (Institut 
Merieux, Lyon France). Induration diameter was measured 
after 72 hours. Tuberculin test was considered positive 
when raised induration was greater than 5 mm in diameter. 
Complete blood count was performed using automated cell 
counter (Coultronics TM, Margency, France), while CD4 cell 
count was also carried out using automated Partec Cyflow 
easy Count Kit (Partec Code No. 05-8401 Western Germany). 
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The absolute CD4 cell number is age dependent in children, 
and the following percentage values was used to define 
the degree of immune suppression, (<15%) was defined 
as severe immunosuppression, (15–24%) as moderate 
suppression, and (>25%) as immunocompetent. WHO 
clinical staging,[14-16] an international four stage system that 
classifies the severity of HIV infection in children was used 
to classify the degree of immunosuppression in the study 
subjects [Appendix].
All patients received anti-tuberculous therapy (ATT), a 
combination of isoniazid, rifampicin, and pyrazinamide 
for six months, with additional steroid (prednisolone) for 
those having meningitic component. HAART was added 
to all patients 2–4 weeks after commencement of ATT. 
Combination of zidovudine or stavudine, lamivudine and 
efavirenz or abacavir were used.
Data analysis was computed using Epi Info 6, and SPSS 
version 13.5 for statistical analysis.
Results
Of a total of 210 HIV-infected children reviewed during 
the 18 months period, 41 (19.5%) were co-infected with 
TB; 19 (46.3%) were males and 22 (53.7%) females giving 
a male to female ratio of 0.9:1. They had a mean age of 
6.3 ± 2.4 years, weight of 14.3 ± 3.4 kg, and a mean CD4 
cell count/percentage of 261.6 ± 28.0 cells/ml and 9.9%, 
signifying severe immune suppression [Table 1]. There was 
no statistical significant difference in the characteristics of 
male and female co-infected children at recruitment.
The site of TB co-infection with HIV and WHO clinical 
staging is shown in Table 2. Pulmonary TB (58.5%) and 
disseminated TB (26.8%) were the commonest form of TB 
seen in HIV patients in the study. Abdominal TB alone 
(7.3%), lymph node (4.9%), and bone (2.4%) were not 
very common. Though disseminated form of TB was not as 
common as pulmonary type, all presented with a mean CD4 
percentage of less than 5.0%. One case of disseminated TB 
had meningitis component, and all the co-infected children 
were in WHO clinical stage 3 and 4.
Age distribution of various types of TB was shown in 
Table 3. TB was significantly commoner in older children 
>5 years than in those <5 years (32 vs 9, P < 0.05). 
All forms of TB were also seen to be commoner in 
older children. Table 4 shows the methods used in the 
diagnosis of TB as well as the sensitivity, specificity, and 
positive predictive values (PPV) of different methods 
used. History of chronic cough of >1month duration and 
history of contact with adult with chronic cough were 
Table 1: Characteristics of the study population



































*Values are mean ± SD. ESR-electrolyte sedimentation rate
Table 2: TB sites and WHO clinical stage






























Total 41 (100) 4 161  7.2
Appendix: Revised WHO clinical staging of HIV/AIDS 
for infants and children
Clinical 
stage I




Disease is manifested by papular puritic eruptions, 
seborrhea dermatitis, fungal nail infections, angular 
chelitis, lineal gingival erythema, extensive human 
papilloma virus (HPV) or mollscum infection 
(>5% of body area/face), recurrent oral ulceration 
(>2 episode/6 months), parotid enlargement, herpes 
zoster (>1 episode/12 months), recurrent or chronic 
upper respiratory infections (URTI): Otitis media, 
otorrhoea, sinusitis (>2 episodes/6 months).
Clinical  
stage III
Features include unexplained moderate malnutrition 
(-2 SD or Z score) not responding to standard 
therapy, unexplained persistent diarrhea (>14 days), 
unexplained persistent fever (intermittent or 
constant, >1 month), oral candidiasis, oral hairy 
leukoplakia, pulmonary tuberculosis, severe recurrent 
presumed bacteria pneumonia (>2 episodes/12 months), 
acute necrotizing ulcerative gingivitis/periodontal, 
lymphoid interstitial pneumonitis, unexplained 
anemia (<8 gm/dl), neutropenia (<1000/ mm3), or 
thrombocytopenia (<30,000/ mm3) for >1 month, HIV 
cardiomyopathy, and HIV-related nephropathy.
Clinical  
stage IV
Presence of unexplained severe wasting or 
severe malnutrition (-3 SD or Z score) not 
responding to standard treatment, pneumocystic 
pneumonia, recurrent severe bacteria infections 
(>2 episodes/12 months, excluding pneumonia), 
chronic orolabial or cutaneous herpes simplex virus 
(lasting >1 month), extra pulmonary TB, Kaposi 
sarcoma, esophageal candidiasis, central nervous 
system toxoplasmosis, cryptoccocal meningitis, any 
disseminated endemic mycosis, cryptosporidiosis or 
isosporiasis (with diarrhea >1 month), cytomegalovirus 
virus infection of organs other than the liver, spleen, 
lymph nodes (and onset age >1 month), disseminated 
mycobacterial disease other than tuberculosis, candida 
of trachea, bronchi or lungs, acquired recto-vesico 
fistula, cerebral or B cell non-Hodgkin lymphoma, 
HIV encephalopathy, and progressive multifocal 
leucoencephalopathy.
Adapted from ‘Interim WHO Clinical Staging of HIV/AIDS Case Definitions 
for Surveillance. African Region’. WHO/HIV/2005.02. http://www. who.int/
hiv/pub/guidelines/clinicalstaging. pdf
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seen in 70.3% and 24.4% of cases. While 95.1% showed 
radiological features suggestive of TB in their chest X-ray, 
AFB was difficult to identify in many body fluids, (9.7% 
from sputum, and none in any other body fluid. Mantoux 
test with indurations of >5 mm was also not very common 
(12.2% only). Confirmation of TB in the study was from 
lymph node histology, and identification of AFB in the 
sputum. While lymph node biopsy showed histological 
features of TB in 12.2% of cases, identification of AFB 
in the sputum was seen in 9.7% of patients, thus giving 
a total of confirmed TB as 21.9%, and 78.1% remained 
unconfirmed or suggestive.
The culture of respiratory specimens, often considers as gold 
standard for diagnosis of TB in adult population, performs 
poorly in children. Firstly, the collection of adequate 
specimen for bacteriological diagnosis from pediatric 
patients is difficult, secondly, the rapid confirmation 
by smear is achieved in less than 15%, with a positive 
culture generally in only 30–40% of cases after a delay 
of 4-8 weeks, and lastly, the natural history of disease 
in children demonstrate that positive Mycobacterium 
tuberculosis culture in a complete asymptomatic child 
recently exposed to TB likely reflects recent infection and 
not active disease.[17,18] Hence there is yet no established 
gold standard for children. However in the absence of 
gold standard method for children, identification of AFB 
in body specimen (sputum), and lymph node histology 
was used as a standard in this review. Going by the 
above, the sensitivity, specificity and PPV of the common 
clinical presentations, signs, and radiological/laboratory 
investigations were carried out in co-infected children 
were tested [Table 4]. The variable tested were history of 
chronic cough for >1 month, severe weight loss, history 
of contact with adult with chronic cough, mantoux test 
with induration of >5 mm, chest x-ray, and non response 
to conventional antibiotics. All showed low to moderate 
sensitivity and specificity with the exception of severe 
weight loss of >-3SD which showed sensitivity/specificity 
of 88.9%, 88.6%, and PPV of 23.0%.
The outcome showed that one patient (2.4%) died from 
disseminated TB, while 2 (4.9%) also having disseminated 
form of TB developed IRS. All patients received ATT, and 
were all started on HAART.
Discussion
TB co-infection with HIV in children is high in this 
environment (19.5%). This is comparable to 17% reported 
among HIV hospitalized children in Peru,[3] 15.2% from 
HIV infected children at Nnewi in Nigeria,[19] and 10% 
from studies from other West African countries.[5] It was 
however much lower than 48.0% report from South African 
study,[16] and also much higher than 5.5% report from United 
Kingdom. [10] Studies have shown that over 90% of 2.3 million 
world children living with HIV reside in the sub Saharan 
Africa. [2,20] Nigeria is one of the countries of sub region that 
have continued to bear the greatest burden of pediatric HIV/
AIDS. Studies have also shown that more than 80% of people 
living with TB reside in the sub-region,[12] and those with HIV 
have 50 times more risk of developing TB in a given year than 
the none infected. TB is a contagious disease spread primarily 
by droplets nuclei expelled by someone who has infectious 
pulmonary or laryngeal TB when they cough or sneeze,[14] It 
can occasionally be contacted by ingestion of contaminated 
unpasturized animal milk. The number/concentration of the 
organism expelled into the air during coughing or sneezing, 
the duration of exposure to infected person, and the condition 
of the immune system of the host are the major factors that 
Table 3: Age distribution and sites of TB in co-infected children











































Total (%)  41 (100)  24 (58.5) 11 (26.8) 3 (7.3) 2 (4.9) 1 (2.4)
TB co-infection in children <5 yrs vs >5 yrs [9 vs 32] P > 0.05
Table 4: Sensitivity, specificity, and positive predictive 
values for various methods used in diagnosis of TB in 
co-infected children
Modalities used for 
TB diagnosis






History of chronic cough 
>1month
10 (24.4) 44.4 92.5 21.1
Positive contact with 
adult with chronic cough
39 (95.1) 55.6 80.1 11.1
Chest x-ray suggestive 3 (7.3) 11.1 82.6 2.1
History of ingestion of 
unpasteurized cow milk
5 (12.2) 22.2 98.5 40.0
Mantoux test >5 mm 
indurations
0 - - -
Gastric lavage/Body fluid 
for AFB
4(9.7) - - -
Sputum for AFB 5 (12.2) - - -
Lymph node biopsy 32 (78.1) 88.9 88.6 23.0
Severe weight loss 29 (70.3) 100.0 80.0 18.4
Not responding to 
conventional AB
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predict the transmission of TB to another person.[14] Close 
contacts are at the highest risk of becoming infected, and 
children acquire this disease from infected adults. TB is equally 
a disease of poverty and easily acquired in over crowded 
environment with low standard of living. This is the true 
picture in most countries in the sub region, and other African 
countries,[19-22] and could explain the high prevalence seen in 
the country.[19,20,23,24] The much higher value (48.0%) however 
reported in South African study might not only be due to 
geographical location of the area, and the disease burden in 
the adult population, but most importantly, the culture proven 
diagnostic technique used in TB diagnosis in South African 
study, which was not applicable in the present study. This 
method appeared more realistic and probably responsible for 
the high figures obtained in their study.
Previous studies among HIV patients have shown great 
association between low CD4 cell counts and susceptibility to 
TB especially extra-pulmonary forms.[3,7] In the present study, 
all the TB co-infected are children were in WHO stages 3 
and 4 diseases of severe imunosuppression. Other workers 
have reported association between low CD4 cell count and 
TB in HIV patients.[22,25] Cohen and co-workers[10] however 
made no such observation. In fact in their report, they 
noted many cases of TB in their co-infected children have 
relatively preserved T-cell function and found no association 
between CD4 cell count and TB manifestation. They however 
attributed such observation to the small number of their study 
population. HIV is notoriously known to cause depletion and 
dysfunction of CD4 cells.
[5,8] Other immunological defects 
caused by this virus include lymphoid tissue destruction, 
CD8 cell and thymic cell dysfunction, B cell abnormalities 
and auto-immune abnormalities.[5,8] The degree of depletion 
of CD4 cell determines the degree of immune suppression. 
The two infections by having the capability of depleting the 
CD4 cell count could explain the reason why the majority of 
patients in the present study had low CD4 cell count.
Diagnosis of TB in HIV children has been very challenging 
especially in poor resource settings because of non-
availability of newer modern methods of diagnosis, and 
overlap of TB and HIV symptoms and signs. In this present 
study, culture proven methods and newer techniques were 
not available. Diagnosis was mainly based on combinations 
of older methods. These include history of contact with adult 
with chronic cough (24.4%), history of cough of greater 
than 1 month duration (70.3%), chest x-ray suggestive of 
pulmonary TB (95.1%), Mantoux test of >5 mm indurations 
(12.2%). While most diagnosis of TB in the present study 
was on presumptive basis (78.0%) with therapeutic trial 
of anti-TB therapy, only 22.0% was confirmed by positive 
sputum and lymph node histology. Even in resource rich 
settings with newer diagnostic facilities, majority of TB in 
co-infected children were treated on presumptive basis, 80% 
by Cohen et al.[10] They did note that therapeutic response 
in all these cases justifies the approach, however, in the 
context of emergence of drug resistant TB, the presumptive 
or therapeutic trial becomes questionable.
Because of the difficulty encountered in the diagnosis of TB 
in poor resource settings like ours, sensitivity and specificity 
with positive predictive values of the common clinical 
presentations, signs, radiological and laboratory test for TB 
were carried out. The aim being to provide information that 
will guide healthcare providers in these areas with limited 
facilities predict infected children at risk of co-infection with 
TB. Severe weight of greater than 3SD below the mean weight 
for age was found to have greater sensitivity and specificity, 
though with lower predictive value, and can be used to predict 
HIV infected children at the risk of co-infection with TB, for 
further evaluation and quick intervention.
Many cases of IRS associated with TB in adult HIV patients 
occurs on commencement of HAART, and several have 
been reported in sub-Saharan Africa.[11,12] Little information 
is available on pediatric patients. Immune reconstitution 
syndrome, defined as paradoxical clinical deterioration after 
starting HAART, resulting from improving immune system 
interaction with organisms that have colonised the body 
during early stages of HIV infection.[5,14] was seen in 2 (4.9%) of 
patients in the presented study, and conforms with the rarity of 
this syndrome in pediatric patients. A wide range of pathogens 
have been known to cause IRS in both adults and children. 
This include Mycobacterium tuberculosis, Mycobacterium 
avium complex (the two organism causing TB), Cryptococcus 
neoformans, Aspergilla, Candida albicans, Pneumocystis jiroveci, 
Cytomegalovirus, Human herpes viruses and Hepatitis B. 
IRS usually presents within 2–6 weeks of commencement 
of HAART. The clinical presentation varies and depends 
on the causative organism. For patients in the present study, 
high fever, generalized lymphadenopathy, development of 
miliary shadows with pleural effusion radiologically were their 
presentation when HAART was introduced 2–3 weeks after 
commencement on ATT. All responded to steroids.
Conclusions
TB co-infection with HIV in children is common in this 
environment. Severe weight loss can be used as a clinical 
guide to identify HIV-infected children at risk of co-infection 
with TB who will require further evaluation and intervention.
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